All terms in EFO
| Label | Id | Description |
|---|---|---|
| 3-Indolepropionic acid to 2-(dimethylamino) guanosine ratio | EFO_0021749 | [Quantification of the ratio of 3-Indolepropionic acid to 2-(dimethylamino) guanosine ratio in a sample.] |
| 3-Indolepropionic acid to SubericAcid ratio | EFO_0021748 | [Quantification of the ratio of 3-Indolepropionic acid to SubericAcid ratio in a sample.] |
| platelet aggregation | GO_0070527 | [The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS.] |
| obsolete_dysostosis of genetic origin | Orphanet_404568 | |
| Polytrichum juniperinum | NCBITaxon_129213 | |
| L-Pyroglutamic acid to 3-Indolepropionic acid ratio | EFO_0021745 | [Quantification of the ratio of L-Pyroglutamic acid to 3-Indolepropionic acid ratio in a sample.] |
| M6A-RIP | EFO_0008789 | [m6A-specific methylated RNA immunoprecipitation (M6A-RIP)] |
| 3-Indolepropionic acid to Creatinine ratio | EFO_0021744 | [Quantification of the ratio of 3-Indolepropionic acid to Creatinine ratio in a sample.] |
| 3-Indolepropionic acid to N,N-Dimethylglycine ratio | EFO_0021747 | [Quantification of the ratio of 3-Indolepropionic acid to N,N-Dimethylglycine ratio in a sample.] |
| 3-Indolepropionic acid to gamma-Linolenic acid (C18:3n6) ratio | EFO_0021746 | [Quantification of the ratio of 3-Indolepropionic acid to gamma-Linolenic acid (C18:3n6) ratio in a sample.] |
| age at initiation of cannabis use | EFO_0021785 | [Age of initiation of the consumption of the drug cannabis.] |
| age at initiation of smoking | EFO_0021784 | [Age of initation of the habit of smoking, the inhaling and exhaling of tobacco smoke.] |
| ascending aortic diameter | EFO_0021787 | [Measurement of the diameter of the ascending aorta.] |
| aortic diameter | EFO_0021786 | [Measurement of the diameter of some part of the aorta.] |
| obsolete_familial atypical multiple mole melanoma syndrome | Orphanet_404560 | |
| age at initiation of corrective lens use | EFO_0021781 | [Age at initiation of the use of corrective lenses, such as glasses or contact lenses, to treat an abnormality of the eye.] |
| age at initiation of treatment | EFO_0021779 | [Age at initiation of a medical treatment, such as a drug, therapy or medical device.] |
| age at initiation of hormone replacement therapy | EFO_0021780 | [Age at initiation of hormone replacement therapy, the therapeutic use of hormones to alleviate the effects of hormone deficiency.] |
| age at medical procedure | EFO_0021783 | [Age at the time of a specific medical procedure or intervention intended to alter the course of a disease.] |
| age at initiation of oral contraceptive pill use | EFO_0021782 | [Age at initiation of the use of an oral contraceptive pill.] |